---
title: "Peraso Expands At-The-Market Equity Offering Capacity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286477868.md"
description: "Peraso Inc. has expanded its at-the-market equity offering capacity by filing a prospectus supplement to issue an additional $670,000 in common stock, following approximately $9.37 million already sold. This move indicates the company's ongoing strategy to raise capital through equity markets, which may lead to shareholder dilution. The legal validity of this expansion is confirmed by a legal opinion. Analysts currently rate PRSO stock as a Buy with a $3.00 price target, although concerns about weak fundamentals and liquidity risks persist."
datetime: "2026-05-14T22:42:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286477868.md)
  - [en](https://longbridge.com/en/news/286477868.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286477868.md)
---

# Peraso Expands At-The-Market Equity Offering Capacity

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest update is out from Peraso ( (PRSO) ).

On May 14, 2026, Peraso Inc. filed a prospectus supplement to increase the maximum amount of common stock that can be issued under its at-the-market offering agreement with Ladenburg Thalmann & Co. Inc. to an additional $670,000 of shares, excluding roughly $9.37 million of stock already sold under the existing arrangement. The shares will continue to be issued under the company’s effective Form S-3 shelf registration and related base prospectus, indicating Peraso’s ongoing use of equity markets to raise incremental capital and potentially impacting existing shareholders through further dilution as the program is utilized.

The prospectus supplement also follows a series of earlier supplements tied to the same registration framework, underscoring that Peraso has been actively updating its offering documentation as it taps the market over time. An accompanying legal opinion from Mitchell Silberberg & Knupp LLP affirms the legality of issuing and selling the additional shares, providing formal assurance regarding the validity of the expanded equity issuance program.

The most recent analyst rating on (PRSO) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Peraso stock, see the PRSO Stock Forecast page.

**Spark’s Take on PRSO Stock**

According to Spark, TipRanks’ AI Analyst, PRSO is a Neutral.

The score is held down primarily by weak fundamentals—ongoing losses, persistent cash burn, and recent revenue contraction—despite low leverage and improving gross margins. Technicals are supportive with price above key moving averages and positive MACD, but near-overbought RSI reduces confidence. Recent updates reinforce liquidity/dilution risk (ATM expansion) and mixed near-term outlook from the earnings call, partially offset by early defense shipment progress.

To see Spark’s full report on PRSO stock, click here.

**More about Peraso**

Peraso Inc. is a publicly traded company that issues common stock with a par value of $0.001 per share and accesses capital markets through an at-the-market equity offering program with Ladenburg Thalmann & Co. Inc. The company utilizes a shelf registration on Form S-3 with the U.S. Securities and Exchange Commission to facilitate ongoing share issuances under this program.

**Average Trading Volume:** 8,773,507

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $13.07M

### Related Stocks

- [PRSO.US](https://longbridge.com/en/quote/PRSO.US.md)
- [SMH.US](https://longbridge.com/en/quote/SMH.US.md)
- [XSD.US](https://longbridge.com/en/quote/XSD.US.md)
- [SOXL.US](https://longbridge.com/en/quote/SOXL.US.md)
- [FTXL.US](https://longbridge.com/en/quote/FTXL.US.md)
- [PSI.US](https://longbridge.com/en/quote/PSI.US.md)
- [SOXX.US](https://longbridge.com/en/quote/SOXX.US.md)

## Related News & Research

- [Peraso Q1 revenue falls 74% on delayed customer order](https://longbridge.com/en/news/285993228.md)
- [Here's why Astera Labs' stock just staged a big gain](https://longbridge.com/en/news/286969770.md)
- [NoMIS Power joins ARPA-E  DC-GRIDS consortium](https://longbridge.com/en/news/286856430.md)
- [Here's How Much $100 Invested In Teradyne 20 Years Ago Would Be Worth Today](https://longbridge.com/en/news/286466208.md)
- [Cerebras raises $5.5B, kicking off 2026’s IPO season with a bang](https://longbridge.com/en/news/286445132.md)